Expanding Diabetes Business Supports ABT Stock, FX Issues Stay
Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose ...
Guidelines needed for interpreting continuous glucose monitoring reports in those without diabetes, say researchers
With the Food and Drug Administration now allowing the over-the-counter purchase of continuous glucose monitors (CGMs)—small ...
drugdeliverybusiness2d
Medtronic seeks to expand MiniMed 780G label to type 2 diabetes, submits new CGM to FDA
Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...
Scientists Identify Cellular “Switch” That May Reverse Diabetes
Mitochondrial stress disrupts insulin production in diabetes, but reversing the damage may restore β-cell function.
FierceBiotech8d
UK court rules against Abbott in diabetes CGM trademark case versus Sinocare
A U.K. court has ruled against Abbott in a trademark infringement case the company had brought over the design of a rival ...
CSR Wire9d
How Myths About Diabetes Have a Real Impact on Health
A lot of things we commonly hear about diabetes may be based on misconceptions or stereotypes. In fact, nearly 40% of people ...
PharmiWeb9d
Glucose Monitoring Devices Market Projected to Hit $ 44.88 Billion by 2034 growing CAGR at 10.18%
The global glucose monitoring devices market was valued at USD 14.1 billion in 2023 and is expected to grow to USD 15.67 ...
CSR Wire10d
A Powerlifter Overcomes the Weight of Diabetes Stigma
As a competitive powerlifter, Nathan Zenero has a unique talent for lifting heavy things. He’s also taken on more than a few challenges in his life, including sports injuries and thyroid cancer.
aha.org13d
FDA warns of potential to miss notifications on smartphone-compatible diabetes devices
The Food and Drug Administration Feb. 5 released an alert notifying patients of a safety concern using diabetes devices such ...